Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time

LNTH 10.23.2024

Full Press ReleaseSEC FilingsOur LNTH Tweets

About Gravity Analytica

Recent News

  • 01.13.2025 - Lantheus' Acquisition of Life Molecular Imaging Conference Call
  • 01.13.2025 - Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
  • 12.18.2024 - Paul K. Choi

Recent Filings

  • 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.15.2025 - 144 Report of proposed sale of securities
  • 01.13.2025 - 8-K Current report
PDF Version

BEDFORD, Mass.,Oct. 23, 2024(GLOBE NEWSWIRE) --Lantheus Holdings, Inc.(the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at8:00 a.m. ETonWednesday, November 6, 2024, to discuss its financial and operating results for the third quarter of 2024.

To access the conference call or webcast, participants should register online athttps://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.

A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.

AboutLantheus

Lantheusis the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered inMassachusettswith offices inCanadaandSweden,Lantheushas been providing radiopharmaceutical solutions for more than 65 years. For more information, visitwww.lantheus.com.

Contacts:

Mark KinarneyVice President, Investor Relations978-671-8842ir@lantheus.com

Melissa DownsSenior Director,External Communications646-975-2533media@lantheus.com

Primary Logo

Source: Lantheus Holdings, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com